We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 122 results
  1. Detection of novel PPP1R1B::STARD3 fusion transcript in acute myeloid leukemia: a case report

    Background

    Acute myeloid leukemia (AML) is the second most common type of leukemia in children. Although prognostic and diagnostic tests of AML...

    Elahe Dehghani Firouzabadi, Mohammed Allami, ... Moein Farshchian in Journal of Medical Case Reports
    Article Open access 05 June 2024
  2. The effects of methylphenidate and atomoxetine on Drosophila brain at single-cell resolution and potential drug repurposing for ADHD treatment

    The stimulant methylphenidate (MPH) and the non-stimulant atomoxetine (ATX) are frequently used for the treatment of attention-deficit/hyperactivity...

    Susu Qu, **angyu Zhou, ... Li Zhang in Molecular Psychiatry
    Article Open access 13 November 2023
  3. Pathological mechanisms and treatment of sporadic Parkinson’s disease: past, present, and future

    For a special issue, we review studies on the pathogenesis of nigral cell death and the treatment of sporadic Parkinson’s disease (sPD) over the past...

    Hideki Mochizuki in Journal of Neural Transmission
    Article Open access 12 June 2024
  4. Shedding a new light on Huntington’s disease: how blood can both propagate and ameliorate disease pathology

    Huntington’s disease (HD) is a monogenic neurodegenerative disorder resulting from a mutation in the huntingtin gene. This leads to the expression of...

    Marie Rieux, Melanie Alpaugh, ... Francesca Cicchetti in Molecular Psychiatry
    Article 08 June 2020
  5. An alternative splicing hypothesis for neuropathology of schizophrenia: evidence from studies on historical candidate genes and multi-omics data

    Alternative splicing of schizophrenia risk genes, such as DRD2 , GRM3 , and DISC1 , has been extensively described. Nevertheless, the alternative...

    Chu-Yi Zhang, **ao **ao, ... Ming Li in Molecular Psychiatry
    Article 08 March 2021
  6. Targeting β-Arrestins in the Treatment of Psychiatric and Neurological Disorders

    Therapies for psychiatric and neurological disorders have been in the development and refinement process for the past 5 decades. Yet, most of these...

    Sharonda S. Harris, Nikhil M. Urs in CNS Drugs
    Article 02 March 2021
  7. Promise and challenges of dystonia brain banking: establishing a human tissue repository for studies of X-Linked Dystonia-Parkinsonism

    X-Linked Dystonia-Parkinsonism (XDP) is a neurodegenerative disease affecting individuals with ancestry to the island of Panay in the Philippines. In...

    Cara Fernandez-Cerado, G. Paul Legarda, ... Geraldine Acuña-Sunshine in Journal of Neural Transmission
    Article Open access 13 January 2021
  8. Amantadine: reappraisal of the timeless diamond—target updates and novel therapeutic potentials

    The aim of the current review was to provide a new, in-depth insight into possible pharmacological targets of amantadine to pave the way to extending...

    Wojciech Danysz, Andrzej Dekundy, ... Peter Riederer in Journal of Neural Transmission
    Article Open access 23 February 2021
  9. Behavioral, neuroanatomical, and molecular correlates of resilience and susceptibility to maternal immune activation

    Infectious or noninfectious maternal immune activation (MIA) is an environmental risk factor for psychiatric and neurological disorders with...

    Flavia S. Mueller, Joseph Scarborough, ... Urs Meyer in Molecular Psychiatry
    Article Open access 23 November 2020
  10. Dopaminergic modulation of striatal function and Parkinson’s disease

    The striatum is richly innervated by mesencephalic dopaminergic neurons that modulate a diverse array of cellular and synaptic functions that control...

    Shenyu Zhai, Weixing Shen, ... D. James Surmeier in Journal of Neural Transmission
    Article 01 April 2019
  11. Signal transduction in l-DOPA-induced dyskinesia: from receptor sensitization to abnormal gene expression

    A large number of signaling abnormalities have been implicated in the emergence and expression of l -DOPA-induced dyskinesia (LID). The primary cause...

    Giada Spigolon, Gilberto Fisone in Journal of Neural Transmission
    Article Open access 02 February 2018
  12. Opiate-associated contextual memory formation and retrieval are differentially modulated by dopamine D1 and D2 signaling in hippocampal–prefrontal connectivity

    Contextual memory driven by abused drugs such as opiates has a central role in maintenance and relapse of drug-taking behaviors. Although dopamine...

    Yunpeng Wang, Hongying Zhang, ... Bo **ng in Neuropsychopharmacology
    Article 17 April 2018
  13. Dopamine receptors: homomeric and heteromeric complexes in l-DOPA-induced dyskinesia

    The current standard treatment for Parkinson disease focuses on restoring striatal dopamine levels using l -3,4-dihydroxyphenylalanine ( l -DOPA)....

    Oscar Solís, Rosario Moratalla in Journal of Neural Transmission
    Article 07 February 2018
  14. CK1δ over-expressing mice display ADHD-like behaviors, frontostriatal neuronal abnormalities and altered expressions of ADHD-candidate genes

    The cognitive mechanisms underlying attention-deficit hyperactivity disorder (ADHD), a highly heritable disorder with an array of candidate genes and...

    Mingming Zhou, Jodi Gresack, ... Marc Flajolet in Molecular Psychiatry
    Article Open access 19 October 2018
  15. Identification of important invasion and proliferation related genes in adrenocortical carcinoma

    Adrenocortical carcinoma (ACC) is an end‐stage hormonal syndrome. Although profound attempts have been made to illuminate the pathogenesis, the...

    Ali Mohamed Alshabi, Basavaraj Vastrad, ... Chanabasayya Vastrad in Medical Oncology
    Article 18 July 2019
  16. Dopamine D2 Receptor Signaling in the Nucleus Accumbens Comprises a Metabolic–Cognitive Brain Interface Regulating Metabolic Components of Glucose Reinforcement

    Appetitive drive is influenced by coordinated interactions between brain circuits that regulate reinforcement and homeostatic signals that control...

    Michael Michaelides, Michael L Miller, ... Yasmin L Hurd in Neuropsychopharmacology
    Article 05 June 2017
  17. Postsynaptic movement disorders: clinical phenotypes, genotypes, and disease mechanisms

    Movement disorders comprise a group of heterogeneous diseases with often complex clinical phenotypes. Overlap** symptoms and a lack of diagnostic...

    Lucia Abela, Manju A. Kurian in Journal of Inherited Metabolic Disease
    Article Open access 13 June 2018
  18. Adult height and risk of 50 diseases: a combined epidemiological and genetic analysis

    Background

    Adult height is associated with risk of several diseases, but the breadth of such associations and whether these associations are primary...

    Florence Y. Lai, Mintu Nath, ... Nilesh J. Samani in BMC Medicine
    Article Open access 25 October 2018
  19. Synaptic plasticity and levodopa-induced dyskinesia: electrophysiological and structural abnormalities

    Parkinson’s disease (PD) is a neurodegenerative disorder characterized by progressive degeneration of dopaminergic neurons located in the midbrain....

    Barbara Picconi, Elvira De Leonibus, Paolo Calabresi in Journal of Neural Transmission
    Article 28 February 2018
  20. Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update—I. Hypokinetic-rigid movement disorders

    Extrapyramidal movement disorders include hypokinetic rigid and hyperkinetic or mixed forms, most of them originating from dysfunction of the basal...

    Kurt A. Jellinger in Journal of Neural Transmission
    Article 18 June 2019
Did you find what you were looking for? Share feedback.